Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Spring 2017 - Safety
Download Issue
Share
Up Front
Publisher's Corner
Making Strides in Patient Safety
By Patrick M. Schmidt
Features
Quality Improvement Programs: Hurdles to Optimizing Care
By
BSTQ Staff
Superbug Apocalypse: A Post-Antibiotic Era?
By
Ronale Tucker Rhodes, MS
Myths and Facts: Obesity
By
Ronale Tucker Rhodes, MS
Autism: Preparing for Aging Out of the System
By
Diane L.M. Cook
BioTrends Watch
Washington Report
CMS Rule Phases Out Pass-Through Payments
HHS Final Rule Protects Research Participants and Modernizes Oversight
21st Century Cures Act Modifies Medicare Payments for Services
Reimbursement FAQs
340B Drug Discount Program in 2017
Industry News
Hemophilia B Gene Therapy Is Effective Despite Immune Reactions
Study Shows High Prevalence of Anti-TSH Receptor Antibody in Fibromyalgia
C.Diff Vaccine Shows Promise in Phase II Trial
IVIG Treatment May Lead to Poorer Outcomes in GBS Patients
Alzheimer’s Could Be Detected Seven Years Prior to Symptoms
FDA Approves Gammaplex 10% to Treat Adult PI and ITP Patients
CDC Changes Recommendation for HPV Vaccine for Children
Ebola Symptoms Absent in Some Infected Persons
Sunlight Produces Faster T Cells to Boost Immunity
Scientists Develop Vaccine to Block Opioid Drugs' Effects
Scientists Discover Post-Exposure Treatment with Horse Antibodies Is Effective for Ebola
No Link Between Flu or Flu Vaccine and Autism, Study Finds
AMA Joins with Other Organizations to Reform Prior-Authorization Requirements
Infusion of BPX-501 T Cells Renders Haplo-HSCT a First-Line Option for Children with PI
Study Identifies Why TB Vaccines Are Ineffective
BioFocus
Industry Insight
Fibrin Sealants: When More Is Needed to Stop the Bleeding
By Keith Berman, MPH, MBA
Patient Profile
Zika Virus: A Patient’s Perspective
By Trudie Mitschang
Physician Profile
Zika Virus: A Physician’s Perspective
By Trudie Mitschang
Disease Profile
Update on Zika Virus
By Jim Trageser
BioSources
BioResearch
Reduced Mortality with Use of Four-Factor Prothrombin Complex Concentrates vs. FFP for Warfarin Reversal: Meta-Analysis
Topical Use of Fibrin Sealant Can Reduce Blood Loss and Need for Transfusion in Total Knee and Hip Arthroplasty